Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Novel RNAi therapeutic significantly reduces triglycerides and LDL

Nov. 12, 2012

Nektar Therapeutics synthesizes promising thymidylate synthase inhibitor

Nov. 9, 2012

T-3256336 proven to be a highly effective inhibitor of tumor growth in vivo

Nov. 9, 2012

Nonviral gene therapy for heart failure presented at AHA meeting

Nov. 9, 2012

Cadila Pharmaceuticals presents clinical results for CADI-05 in bladder cancer

Nov. 8, 2012

Aileron Therapeutics develops new oncology drug candidate

Nov. 8, 2012

Cardiovascular benefits demonstrated for SIRT1 activator SRT-2104 in smokers

Nov. 8, 2012

Novel strategies for lipid management: SOAT inhibitor PRD-017

Nov. 8, 2012

Avaxia Biologics presents promising in vivo results for AVX-470m

Nov. 8, 2012

Long-term clinical remission and mucosal healing demonstrated with golimumab

Nov. 7, 2012

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...